Post Archive by Year

Recent data published in England and the United States show high levels of patients diagnosed with norovirus, the winter vomiting bug, as the end of 2023 approaches.
The timing of norovirus outbreaks can vary considerably from one season to the next, says the U.K. Health Security Agency.
According to the U.K.'s NHS, an average of 351 people were hospitalized with diarrhea and vomiting symptoms every day at the end of November compared to 126 in the same week in 2022.

According to a recent announcement, a much anticipated human immunodeficiency virus (HIV) vaccine clinical trial that began in December 2020 has been discontinued in Africa because there is little or no chance of the trial demonstrating vaccine efficacy in preventing HIV acquisition.
On December 6, 2023, the PrEPVacc clinical trial leadership announced they decided to stop vaccinations based on the recommendation of its independent data monitoring committee (IDMC).

World leaders recently announced new commitments that help implement the Paris Pact principles, combining official development assistance and private investment, and support the objective of achieving polio eradication by 2026.

Before attending your next holiday event, there is one COVID-19 vaccine standing out in the crowded immunology market in late 2023.
While COVID-19 cases continue to escalate entering the holiday season, getting a booster dose now may be just what the doctor ordered.
Health experts at the U.S. Centers for Disease Control and Prevention (CDC) recently confirmed that despite COVID-19 fatigue, our best defense is getting vaccinated before visiting friends and family.

Several health reports have recently confirmed that sexually transmitted infections (STIs) have reached a record high for an eighth consecutive year. 
Cases of chlamydia, gonorrhea, and syphilis have been impacting the health of teenagers, college students, and young adults more than ever.
The U.S. Centers for Disease Control and Prevention (CDC) reported these bacteria-related STIs reached more than 2.5 million people over the past year. 

From a modest start in February 2000, ClinicalTrials.gov has become a critical part of the U.S. Food and Drug Administration's (FDA) efforts to protect public health.
Making clinical trial information publicly available fulfills the FDA's commitment to research participants and also enhances public trust.
Another significant benefit is the sharing of unfavorable study results.
Before launching ClinicalTrials.gov, many (vaccine) studies went unreported in the scientific literature, leading to a biased perspective on the benefits and risks of interventions.

The Centers for Disease Control and Prevention (CDC) recently published the latest information on pediatric pneumonia.
Released on December 1, 2023, this data shows the weekly percent of emergency department visits diagnosed with pneumonia is mainly consistent with previous years for children aged 0 to 4 years, with slight increases for those aged 5 to 17 years.
The U.S. National Syndromic Surveillance Program data as of November 25, 2023, indicated that the weekly percent of emergency department visits with diagnosed pneumonia was as follows:

Associations seen between long COVID and negative affect, as well as physical mobility and cognitive issues